BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18984314)

  • 1. [Uterine cervix smears: their strengths and weaknesses in 2008].
    Vacher-Lavenu MC
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S87-9. PubMed ID: 18984314
    [No Abstract]   [Full Text] [Related]  

  • 2. [The HPV test in primary cervical cancer screening].
    Bergeron C
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S90-1. PubMed ID: 18984315
    [No Abstract]   [Full Text] [Related]  

  • 3. [What strategy should be adopted for the screening of uterine cervix adenocarcinoma? ].
    Bourgain C
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S94-5. PubMed ID: 18984317
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cervical cancer screening and the place of the HPV test in 2012].
    Bosch FX; Bergeron C
    Ann Pathol; 2012 Nov; 32(5 Suppl):S22-3. PubMed ID: 23127928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic importance of ProEx C in gynecologic cytopathology].
    Tambouret RH
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S92-3. PubMed ID: 18984316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Papillomavirus screening: shall it be performed systematically?].
    Agius G; Beby-Defaux A
    Transfus Clin Biol; 2003 Apr; 10(2):86-9. PubMed ID: 12763151
    [No Abstract]   [Full Text] [Related]  

  • 7. The known unknowns of HPV natural history.
    Gravitt PE
    J Clin Invest; 2011 Dec; 121(12):4593-9. PubMed ID: 22133884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human papilloma virus infection and cervical cancer: a public health perspective].
    Torres-Poveda KJ; Burguete A; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2008; 60(5):414-20. PubMed ID: 19227439
    [No Abstract]   [Full Text] [Related]  

  • 9. Further analysis of the ARTISTIC trial.
    Sasieni P; Castle PE; Cuzick J
    Lancet Oncol; 2009 Sep; 10(9):841-2; author reply 842-3. PubMed ID: 19717086
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
    Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
    J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and quantification of human papillomavirus genital infections: virological, epidemiological, and clinical applications].
    Carcopino X; Henry M; Olive D; Boubli L; Tamalet C
    Med Mal Infect; 2011 Feb; 41(2):68-79. PubMed ID: 20828954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods of cervical cancer screening and facing new problems in China].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopsy in the diagnosis of human papilloma virus in the context of a vaccine].
    Curiel-Valdés Jde J
    Cir Cir; 2008; 76(1):1-3. PubMed ID: 18492413
    [No Abstract]   [Full Text] [Related]  

  • 17. Cervical disease in women referred to colposcopy following inadequate smears.
    Hollingworth J; Kotecha K; Dobbs SP; Shaw PA; Ireland D
    Cytopathology; 2000 Feb; 11(1):45-52. PubMed ID: 10714375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Bode-Lesniewska B; Caduff R
    Praxis (Bern 1994); 2017; 106(6):305-310. PubMed ID: 28300000
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Pap test in HIV-positive women].
    Carlucci M; Cimmino A; Fiore MG; Lepera A; Tantimonaco L; Ricco R
    Pathologica; 2001 Dec; 93(6):651-3. PubMed ID: 11785116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.